pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

3,219 catalysts · 3,045 8k filing · 2,091 grant · 1,128 approval · 1,000 device adverse event · 848 device 510k · 610 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×from 2026-01-08×clear all
type
  • 8k filing3,045
  • grant2,091
  • approval1,128
  • device adverse event1,000
  • device 510k848
  • device pma610
earnings
579
  • device recall318
  • recall215
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 5, 2026

    21
    ›Jan 8, 2026approval215d agoENSACOVE (ENSARTINIB HYDROCHLORIDE) — FDA approvalensartinib hydrochloride

    Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL

    full page →ensartinib hydrochloride →fda approvals ↗
    ›Jan 8, 2026approval215d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 8, 2026approval215d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 8, 2026approval215d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 8, 2026approval215d agoSAPROPTERIN DIHYDROCHLORIDE — FDA approvalSAPROPTERIN DIHYDROCHLORIDE

    Sponsor: MICRO LABS. Form: POWDER. Route: ORAL

    full page →SAPROPTERIN DIHYDROCHLORIDE →fda approvals ↗
    ›Jan 8, 2026approval215d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: TORRENT. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 8, 2026approval215d agoMAGNESIUM SULFATE — FDA approvalMAGNESIUM SULFATE

    Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

    full page →MAGNESIUM SULFATE →fda approvals ↗
    ›Jan 8, 2026approval215d agoFLUCONAZOLE — FDA approvalDiflucan

    Sponsor: FDC LTD. Form: TABLET. Route: ORAL

    full page →Diflucan →fda approvals ↗
    ›Jan 8, 2026approval215d agoFUROSEMIDE — FDA approvalFurosemide Sun

    Sponsor: MICRO LABS. Form: INJECTABLE. Route: INJECTION

    full page →Furosemide Sun →fda approvals ↗
    ›Jan 8, 2026approval215d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 8, 2026grant215d agoALASKA NATIVE TRIBAL HEALTH CONSORTIUM — Traditional foods and health: A Community-Based Approach to Improving Food Se...

    GM grant. $140,056. PI: Ruby Fried

    full page →nih reporter ↗
    ›Jan 9, 2026approval214d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Jan 9, 2026approval214d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

    Sponsor: ABHAI LLC. Form: SOLUTION. Route: ORAL

    full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
    ›Jan 9, 2026approval214d agoAMITRIPTYLINE HYDROCHLORIDE — FDA approvalAlgoTherapeutix SAS

    Sponsor: UNIQUE PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 9, 2026approval214d agoVARENICLINE TARTRATE — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: UMEDICA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 9, 2026approval214d agoEVEROLIMUS — FDA approvalEVEROLIMUS

    Sponsor: BIOCON PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →EVEROLIMUS →fda approvals ↗
    ›Jan 9, 2026approval214d agoNEXLETOL (BEMPEDOIC ACID) — FDA approvalbempedoic acid

    Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL

    full page →bempedoic acid →fda approvals ↗
    ›Jan 9, 2026approval214d agoNEXLIZET (BEMPEDOIC ACID) — FDA approval(bempedoic acid + ezetimibe)

    Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL

    full page →(bempedoic acid + ezetimibe) →fda approvals ↗
    ›Jan 9, 2026approval214d agoPHYTONADIONE — FDA approvalSigyn Therapeutics, Inc.

    Sponsor: SUNNY. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 9, 2026grant214d agoSANFORD RESEARCH NORTH — Momentary predictors and moderators of eating disorder behaviors and self-harm

    GM grant. $312,417. PI: Dorian R Dodd

    full page →nih reporter ↗
    ›Jan 9, 2026grant214d agoUNIVERSITY OF TOLEDO HEALTH SCI CAMPUS — Influence of arginine on Klebsiella pneumoniae mucoidy and pathogenesis

    AI grant. $39,066. PI: Brooke Ring

    full page →nih reporter ↗

    Week of Jan 12, 2026

    29
    ›Jan 12, 2026approval211d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 12, 2026approval
    ← prev
    page 1 of 65
    next →
    211d ago
    TOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: ASCENT PHARMS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Jan 12, 2026approval211d agoFLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (FLUTICASONE PROPIONATE) — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: RESPIRENT PHARMS. Form: POWDER. Route: INHALATION

    full page →fda approvals ↗
    ›Jan 12, 2026approval211d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 12, 2026approval211d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Jan 12, 2026approval211d agoZYCUBO (COPPER HISTIDINATE) — FDA approvalcopper histidinate

    Sponsor: SENTYNL THERAPS INC. Form: POWDER. Route: SUBCUTANEOUS

    full page →copper histidinate →fda approvals ↗
    ›Jan 12, 2026grant211d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Exploring leaderless mRNA translation, a potential Achilles heel of mycobacteriaUniversity of California San Francisco

    AI grant. $75,052. PI: Sarah C Feid

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoARKANSAS CHILDREN'S HOSPITAL RES INST — Growing Healthy Children and Families in Rural Arkansas

    GM grant. $132,469. PI: Martha Rojo

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoUNIVERSITY OF COLORADO — Adolescent Friendship Networks: Effects on Immigrant Youth’s Psychosocial Health

    HD grant. $248,995. PI: Thoa Khuu

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Mechanistic Insights Underlying LZTR1-Related SchwannomatosisNew York University

    NS grant. $579,610. PI: Pau Castel

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR — STRONG HEART STUDY (SHS) - UNIVERSITY OF OKLAHOMA, FIELD CENTER (FC), TASK AR...

    HL grant. $469,049. PI: nagendra monangi

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoMISSOURI BREAKS RESEARCH, INC. — STRONG HEART STUDY (SHS) - MISSOURI BREAKS INDUSTRIES RESEARCH, INC., FIELD C...

    HL grant. $154,846. PI: HELAINE E. RESNICK

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoMEDSTAR HEALTH RESEARCH INSTITUTE — STRONG HEART STUDY (SHS) - MEDSTAR HEALTH RESEARCH INSTITUTE, INC., FIELD CEN...

    HL grant. $129,024. PI: DEDRA S BUCHWALD

    full page →nih reporter ↗
    ›Jan 12, 2026grant211d agoCOLORADO STATE UNIVERSITY — Transmission dynamics and fitness of reemerging St. Louis encephalitis virus ...

    AI grant. $87,244. PI: Jenny Ann Buczek

    full page →nih reporter ↗
    ›Jan 13, 2026approval210d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 13, 2026approval210d agoYESAFILI (AFLIBERCEPT-JBVF) — FDA approvalYESAFILI

    Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION

    full page →YESAFILI →fda approvals ↗
    ›Jan 13, 2026approval210d agoSODIUM BICARBONATE — FDA approvalSODIUM BICARBONATE

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAVENOUS

    full page →SODIUM BICARBONATE →fda approvals ↗
    ›Jan 13, 2026approval210d agoISOVUE-250 (IOPAMIDOL) — FDA approval

    Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 13, 2026approval210d agoISOVUE-370 (IOPAMIDOL) — FDA approval

    Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 13, 2026approval210d agoBENAZEPRIL HYDROCHLORIDE — FDA approvalBENAZEPRIL HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →BENAZEPRIL HYDROCHLORIDE →fda approvals ↗
    ›Jan 13, 2026approval210d agoDEFLAZACORT — FDA approvalDEFLAZACORT

    Sponsor: ZYDUS LIFESCIENCES. Form: SUSPENSION. Route: ORAL

    full page →DEFLAZACORT →fda approvals ↗
    ›Jan 13, 2026grant210d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic s...City of Hope

    DK grant. $450,479. PI: Zhijian Qian

    full page →nih reporter ↗
    ›Jan 14, 2026approval209d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval209d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval209d agoMEN'S ROGAINE (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval209d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval209d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Jan 14, 2026approval209d agoROGAINE (FOR WOMEN) (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval209d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    $ESPR
    $IGC0.2670+0.41%
    $ESPR
    $IGC0.2670+0.41%
    $SIGY0.04000.00%
    $AMRX17.88-1.43%
    $AMRX17.88-1.43%
    $HCWB
    $MANE110.75-3.18%
    $MANE110.75-3.18%